AI in HEOR is here to stay, but there is often a gulf between understanding AI regulations and effectively implementing Generative AI responsibly. In this webinar, we will explore, in an interesting and accessible manner, both regulatory and HTA perspectives and actual use cases.

To set the scene, we will discuss regulatory and HTA perspectives from EMA, FDA, and NICE, describing the current state of play. Then we will demonstrate two use cases: first, how to streamline literature reviews with transparent, traceable workflows; and second, how to summarize NICE documents, allowing you to answer key HEOR questions in seconds.

Key Topics

• The current state of AI development in HEOR
• Recent regulatory guidance and impact
• Use of AI in literature reviews
• AI for NICE document summarization

Speakers

• Manuel Cossio, Director, Innovation and Strategic Consulting
• Dalia Dawoud, Research Principal, HTA Policy and Strategy
• Sheena Singh, Manager, Evidence Review and Software
• Cale Harrison, Associate Director, Evidence, Value, and Access